- Home
- TALK vs TRDA Comparison
TALK vs TRDA Comparison
Compare TALK & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALK
- TRDA
- Stock Information
- Founded
- TALK 2012
- TRDA 2016
- Country
- TALK United States
- TRDA United States
- Employees
- TALK N/A
- TRDA N/A
- Industry
- TALK Medical/Nursing Services
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- TALK Health Care
- TRDA Health Care
- Exchange
- TALK Nasdaq
- TRDA Nasdaq
- Market Cap
- TALK 469.9M
- TRDA 502.9M
- IPO Year
- TALK N/A
- TRDA 2021
- Fundamental
- Price
- TALK $2.67
- TRDA $8.13
- Analyst Decision
- TALK Buy
- TRDA Strong Buy
- Analyst Count
- TALK 6
- TRDA 3
- Target Price
- TALK $4.50
- TRDA $25.67
- AVG Volume (30 Days)
- TALK 1.7M
- TRDA 168.7K
- Earning Date
- TALK 05-06-2025
- TRDA 05-06-2025
- Dividend Yield
- TALK N/A
- TRDA N/A
- EPS Growth
- TALK N/A
- TRDA N/A
- EPS
- TALK 0.01
- TRDA 1.68
- Revenue
- TALK $187,593,000.00
- TRDA $210,782,000.00
- Revenue This Year
- TALK $23.45
- TRDA N/A
- Revenue Next Year
- TALK $21.15
- TRDA N/A
- P/E Ratio
- TALK $391.75
- TRDA $4.84
- Revenue Growth
- TALK 25.02
- TRDA 63.38
- 52 Week Low
- TALK $1.60
- TRDA $7.10
- 52 Week High
- TALK $4.36
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- TALK 44.17
- TRDA 35.90
- Support Level
- TALK $2.63
- TRDA $7.56
- Resistance Level
- TALK $2.94
- TRDA $8.72
- Average True Range (ATR)
- TALK 0.18
- TRDA 0.66
- MACD
- TALK 0.02
- TRDA 0.07
- Stochastic Oscillator
- TALK 44.23
- TRDA 44.02
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.